Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs PROCTER & GAMBLE HEALTH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA PROCTER & GAMBLE HEALTH ASTRAZENECA PHARMA/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 91.6 34.6 264.6% View Chart
P/BV x 16.6 11.4 145.1% View Chart
Dividend Yield % 0.3 1.3 23.6%  

Financials

 ASTRAZENECA PHARMA   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-22
PROCTER & GAMBLE HEALTH
Jun-22
ASTRAZENECA PHARMA/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs4,5805,850 78.3%   
Low Rs2,5293,925 64.4%   
Sales per share (Unadj.) Rs322.2671.3 48.0%  
Earnings per share (Unadj.) Rs24.6116.0 21.2%  
Cash flow per share (Unadj.) Rs31.4132.3 23.8%  
Dividends per share (Unadj.) Rs10.0052.50 19.0%  
Avg Dividend yield %0.31.1 26.2%  
Book value per share (Unadj.) Rs203.8367.0 55.5%  
Shares outstanding (eoy) m25.0016.60 150.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x11.07.3 151.5%   
Avg P/E ratio x144.342.1 342.3%  
P/CF ratio (eoy) x113.136.9 306.2%  
Price / Book Value ratio x17.413.3 131.0%  
Dividend payout %40.645.3 89.7%   
Avg Mkt Cap Rs m88,86381,132 109.5%   
No. of employees `000NANA-   
Total wages/salary Rs m2,3021,676 137.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m8,05611,144 72.3%  
Other income Rs m148132 111.9%   
Total revenues Rs m8,20411,276 72.8%   
Gross profit Rs m8622,677 32.2%  
Depreciation Rs m170271 62.6%   
Interest Rs m104 226.2%   
Profit before tax Rs m8302,534 32.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m214609 35.2%   
Profit after tax Rs m6161,925 32.0%  
Gross profit margin %10.724.0 44.5%  
Effective tax rate %25.824.0 107.5%   
Net profit margin %7.617.3 44.3%  
BALANCE SHEET DATA
Current assets Rs m7,6539,895 77.3%   
Current liabilities Rs m3,9236,117 64.1%   
Net working cap to sales %46.333.9 136.6%  
Current ratio x2.01.6 120.6%  
Inventory Days Days61263 23.3%  
Debtors Days Days39273 14.2%  
Net fixed assets Rs m2,1209,540 22.2%   
Share capital Rs m50166 30.1%   
"Free" reserves Rs m5,0445,926 85.1%   
Net worth Rs m5,0946,092 83.6%   
Long term debt Rs m00-   
Total assets Rs m9,77319,435 50.3%  
Interest coverage x88.4604.3 14.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.6 143.8%   
Return on assets %6.49.9 64.5%  
Return on equity %12.131.6 38.3%  
Return on capital %16.541.7 39.6%  
Exports to sales %00-   
Imports to sales %31.711.3 279.6%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m2,5521,263 202.1%   
Fx inflow Rs m4421,226 36.0%   
Fx outflow Rs m2,5521,263 202.1%   
Net fx Rs m-2,110-37 5,749.3%   
CASH FLOW
From Operations Rs m1,0081,695 59.5%  
From Investments Rs m47-255 -18.6%  
From Financial Activity Rs m-95-2,886 3.3%  
Net Cashflow Rs m961-1,447 -66.4%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 51.9 144.6%  
Indian inst/Mut Fund % 3.8 18.7 20.4%  
FIIs % 2.5 6.1 41.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 48.2 51.9%  
Shareholders   49,085 65,148 75.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   CIPLA    DR. REDDYS LAB    SUN PHARMA    LUPIN    AUROBINDO PHARMA    


More on ASTRAZENECA PHARMA vs Procter & Gamble Health

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs Procter & Gamble Health Share Price Performance

Period ASTRAZENECA PHARMA Procter & Gamble Health S&P BSE HEALTHCARE
1-Day 1.14% 0.69% -0.89%
1-Month -5.01% -0.67% -1.85%
1-Year 9.62% -21.58% -6.83%
3-Year CAGR 6.91% -0.59% 20.56%
5-Year CAGR 23.98% 30.10% 10.73%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the Procter & Gamble Health share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of Procter & Gamble Health the stake stands at 51.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of Procter & Gamble Health.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 40.6%.

Procter & Gamble Health paid Rs 52.5, and its dividend payout ratio stood at 45.3%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of Procter & Gamble Health.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 4-Day Losing Streak, Gains 160 Points | Bank Nifty Gains 1% to Hit Record High | PSU Bank Stocks Rally(Closing)

After opening the day on a flat note, Indian share markets extended gains during the last hour of trade to end higher.